Drug intelligence / Profile preview

jiedu tongmai granule

Development stage: Unknown
Lead developer: Huashen Pharmaceutical
Administration: Oral

Overview

Jiedu Tongmai granule is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of diabetic foot and complications associated with type 2 diabetes mellitus. The drug is based on the TCM therapeutic principle of "detoxification and collateralization" (Jiedu Tongmai), which aims to clear heat, resolve toxins, and improve blood circulation through the body's collateral vessels. It is primarily investigated by Shunyi Hospital and Beijing Traditional Chinese Medicine Hospital to promote the healing of chronic ulcers and improve vascular outcomes in diabetic patients. The formulation is typically administered orally as a granule.

Other names: Jiedu Tongmai解毒通脉颗粒Jiedu Tongmai granule

Beyond the preview

Go deeper on jiedu tongmai granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on jiedu tongmai granule.

Explore the full profile